Suboxone manufacturer pays R.I. $5.4M settlement over improper promotion of drug

By
-
RHODE ISLAND has received $5.4 million from the manufacturer of Suboxone to settle allegations of improper marketing and promotion. / BLOOMBERG NEWS FILE PHOTO/JOHN MOORE
RHODE ISLAND has received $5.4 million from the manufacturer of Suboxone to settle allegations of improper marketing and promotion. / BLOOMBERG NEWS FILE PHOTO/JOHN MOORE
PROVIDENCE – Reckitt Benckiser Group has agreed to pay Rhode Island $5.2 million in a settlement over allegations that it improperly marketed and promoted the drug Suboxone, resulting in improper state Medicaid expenditures, R.I. Attorney General Peter F. Neronha announced Monday. Rhode Island’s settlement is part of a larger $700 million settlement with six states…

Thanks for reading Providence Business News. Create your free account or log in to continue reading.


Register Now Already a Subscriber? Login now


 

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

- Advertisement -

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

RELATED ARTICLESMORE FROM AUTHOR

No posts to display